This case report suggests that scalp arteriovenous malformations can cause local hair loss, which may recover following ethanol embolization treatment.
January 2025 in “International Journal of Pharmacognosy and Life Science” In this review, researchers highlighted the potential benefits of using herbal remedies, such as Aloe vera, Bhringraj, Neem, Tea tree oil, Amla, and Hibiscus, for treating various hair problems like dandruff, scalp infections, and premature greying, suggesting natural alternatives to traditional hair treatments.
November 2024 in “Journal of Investigative Dermatology” Reishi mushroom extract may help treat hair loss.
March 2024 in “Pakistan Journal of Pharmaceutical Sciences” This study found that minoxidil nanoliposomes led to faster hair growth and better scalp bacteria reduction in mice compared to traditional minoxidil.
February 2020 in “International Journal of Research in Dermatology” This study emphasizes that erosive pustular dermatosis of the scalp is an underrecognized condition, and increased awareness and diagnosis can improve patient outcomes by preventing further scalp damage.
December 2002 in “International Journal of Cosmetic Surgery and Aesthetic Dermatology” This review covers preoperative considerations and surgical techniques for scalp reduction in hair restoration, noting its potential to provide natural, dense coverage for large vertex defects unachievable by traditional grafting.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source establishes prior art for treating androgenic alopecia and sexual dysfunction by restoring gap-junction-mediated connectivity in tissue networks, highlighting a mechanism independent of commonly targeted pathways.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source discusses defensive publication regarding methods to treat androgenic alopecia and sexual dysfunction by restoring gap-junction-mediated connectivity, highlighting a unique mechanism independent of membrane voltage and not targeted by current treatments.
July 2025 in “Journal of Investigative Dermatology” This study found that autologous Foxp3+ γδTregs, when tested in human scalp hair follicle models and mouse xenotransplants, can both prevent and treat alopecia areata by reducing immune privilege collapse and lymphocytic infiltration, suggesting their potential as a novel cell-based therapy for the disease.
This review discusses the use of botulinum toxin for hair and scalp disorders and reports mixed findings, with most studies showing mild or non-significant effects on hair growth.
In this study, researchers describe a technique for preparing mesenchymal stem cells to optimize hair transplantation for androgenetic alopecia, highlighting future plans to assess stem cell characteristics and hair density improvements through flow cytometry and trichoscopy.
July 2024 in “Medical alphabet” In this case report, a 9-year-old with alopecia areata experienced full hair regrowth after six months of oral tofacitinib, with no recurrence or significant side effects for a year post-treatment.
August 2016 in “Journal of Investigative Dermatology” This study found that Rosebay extract significantly reduced dandruff and sebum production, suggesting it may be an effective anti-dandruff ingredient as a complement or alternative to antifungal treatments.
13 citations
,
June 2012 in “Dermatologic Surgery” This review discusses treatment strategies for managing scarring based on severity using volume, surface, and movement interventions, but does not present new experimental results.
June 2019 in “Journal of Dermatological Treatment” This study reported that a novel filler, BM-PHA, demonstrated similar efficacy and safety to Restylane Perlane in treating moderate to severe nasolabial folds over 24 weeks, showing only minor local side effects and similar improvements in wrinkle severity scores between the two treatments.
104 citations
,
August 2008 in “Clinics in Dermatology” This review discusses current treatment challenges and strategies for managing psoriasis in the scalp, nails, and intertriginous areas, emphasizing the need for effective and well-tolerated long-term options, but reports no new clinical results.
9 citations
,
November 2008 in “Facial Plastic Surgery” This article reviews techniques for repairing scalp deformities and concludes that combining older methods with modern hair restoration allows for satisfactory treatment of large scarred areas.
37 citations
,
January 2000 in “International Journal of Pharmaceutics” In a study using human scalp skin grafts on SCID mice, topical flutamide and finasteride significantly improved hair growth in male-pattern baldness compared to placebo, with flutamide showing superior results to finasteride.
36 citations
,
December 2012 in “Dermatologic Surgery” Injecting platelet-rich plasma (PRP) can increase hair growth rate and density in male pattern baldness.
19 citations
,
September 2014 in “British Journal of Dermatology” This study found that topical minoxidil 5% foam was effective in promoting hair growth in both the frontal and vertex scalp for men with androgenetic alopecia.
8 citations
,
September 1993 in “British journal of dermatology/British journal of dermatology, Supplement” This study reports a new method for efficiently isolating hair papillae and follicle epithelium from human scalp specimens but presents no clinical results.
2 citations
,
September 2023 in “Cosmetics” This study reviewed existing research on the use of cannabinoids for hair, scalp, and skin conditions, finding moderate evidence for their efficacy in conditions like atopic dermatitis and psoriasis, but noted limited evidence and no standardized guidelines for treatment.
November 2025 in “JEADV Clinical Practice” In this case report, a 28-year-old woman's tinea capitis, diagnosed using a Wood's lamp, was successfully treated with oral itraconazole and ketoconazole shampoo over eight weeks.
May 2025 in “Orphanet Journal of Rare Diseases” This review suggests that immunomodulators, including TNF-α blockers and IL inhibitors, may improve symptoms of moderate-to-severe dissecting cellulitis of the scalp, but their effects on hair regrowth and scarring remain unclear.
This study suggests that topically applied thyroid hormones T3 and T4 promote hair growth on human scalp tissues ex vivo, highlighting potential therapeutic use for hair loss conditions like androgenetic alopecia.
This study found that applying transfer learning with CNN architectures like AlexNet, VGG16, and ResNet50 achieved 99% accuracy in classifying multiclass hair disorders, suggesting a potential technological aid for dermatologists in diagnosing and treating hair conditions.
Ritlecitinib significantly regrows scalp hair in people with alopecia areata.
June 2023 in “Plastic and Reconstructive Surgery” In this study, autologous hair follicle mesenchymal stem cell therapy was effective in promoting hair growth in Chinese patients with advanced androgenic alopecia, particularly improving hair shaft diameter in follicles less than 60 µm without obvious side effects.
May 2016 in “International Society of Hair Restoration Surgery” This abstract describes a prior case of a patient who underwent a hair transplant to address alopecia resulting from radiation therapy; it contains no new findings.
May 2015 in “Journal of The American Academy of Dermatology” Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.